Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.074 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |